These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36521659)

  • 1. Dysfunctional Extracellular Matrix Remodeling Supports Perianal Fistulizing Crohn's Disease by a Mechanoregulated Activation of the Epithelial-to-Mesenchymal Transition.
    Rizzo G; Rubbino F; Elangovan S; Sammarco G; Lovisa S; Restelli S; Pineda Chavez SE; Massimino L; Lamparelli L; Paulis M; Maroli A; Roda G; Shalaby M; Carvello M; Foppa C; Drummond SP; Spaggiari P; Ungaro F; Spinelli A; Malesci A; Repici A; Day AJ; Armuzzi A; Danese S; Vetrano S
    Cell Mol Gastroenterol Hepatol; 2023; 15(3):741-764. PubMed ID: 36521659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perianal fistulizing Crohn's disease: pathogenesis, diagnosis and therapy.
    Panés J; Rimola J
    Nat Rev Gastroenterol Hepatol; 2017 Nov; 14(11):652-664. PubMed ID: 28790453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for tumor necrosis factor and bacterial antigens in the pathogenesis of Crohn's disease-associated fistulae.
    Frei SM; Pesch T; Lang S; Weber A; Jehle E; Vavricka SR; Fried M; Rogler G; Scharl M
    Inflamm Bowel Dis; 2013 Dec; 19(13):2878-87. PubMed ID: 24189042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of CD3+CD8- and CD3+CD8+ T Cells to TNF-α Overexpression in Crohn Disease-Associated Perianal Fistulas and Induction of Epithelial-Mesenchymal Transition in HT-29 Cells.
    Bruckner RS; Spalinger MR; Barnhoorn MC; Feakins R; Fuerst A; Jehle EC; Rickenbacher A; Turina M; Niechcial A; Lang S; Hawinkels LJAC; van der Meulen-de Jong AE; Verspaget HW; Rogler G; Scharl M
    Inflamm Bowel Dis; 2021 Mar; 27(4):538-549. PubMed ID: 33146394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Phase IB/IIA Study of Ex Vivo Expanded Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease.
    Lightner AL; Reese J; Ream J; Nachand D; Jia X; Dadgar N; Steele SR; Hull T
    Dis Colon Rectum; 2023 Oct; 66(10):1359-1372. PubMed ID: 36602511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardization of mesenchymal stromal cell therapy for perianal fistulizing Crohn's disease.
    Molendijk I; van der Meulen-de Jong AE; Verspaget HW; Veenendaal RA; Hommes DW; Bonsing BA; Peeters KCMJ
    Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1148-1154. PubMed ID: 30095479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role for SNAIL family transcription factors in the etiology of Crohn's disease-associated fistulae.
    Scharl M; Weber A; Fürst A; Farkas S; Jehle E; Pesch T; Kellermeier S; Fried M; Rogler G
    Inflamm Bowel Dis; 2011 Sep; 17(9):1907-16. PubMed ID: 21830269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Durable Response in Patients With Refractory Fistulizing Perianal Crohn's Disease Using Autologous Mesenchymal Stem Cells on a Dissolvable Matrix: Results from the Phase I Stem Cell on Matrix Plug Trial.
    Dozois EJ; Lightner AL; Dietz AB; Fletcher JG; Lee YS; Friton JJ; Faubion WA
    Dis Colon Rectum; 2023 Feb; 66(2):243-252. PubMed ID: 36538706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial-to-mesenchymal transition in a fistula-associated anal adenocarcinoma in a patient with long-standing Crohn's disease.
    Scharl M; Frei P; Frei SM; Biedermann L; Weber A; Rogler G
    Eur J Gastroenterol Hepatol; 2014 Jan; 26(1):114-8. PubMed ID: 24284372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Neutrophil Extracellular Traps with Fistula Healing in Patients with Complex Perianal Fistulizing Crohn's Disease.
    Cao D; Qian K; Zhao Y; Hong J; Chen H; Wang X; Yang N; Zhang C; Cao J; Jia K; Wu G; Zhu M; Shen J; Zhang Y; Cui Z; Wang Z
    J Crohns Colitis; 2023 Apr; 17(4):580-592. PubMed ID: 36322703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase I Study of Ex Vivo Expanded Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Pediatric Perianal Fistulizing Crohn's Disease.
    Lightner AL; Otero-Pineiro A; Reese J; Ream J; Nachand D; Adams AC; VanDenBossche A; Kurowski JA
    Inflamm Bowel Dis; 2023 Dec; 29(12):1912-1919. PubMed ID: 37263018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and MRI Evolution After Local Injection of Bone Marrow-Derived Mesenchymal Stem Cells in Perianal Fistulae in Crohn's Disease: Results From a Prospective Monocentric Study.
    Reenaers C; Gillard RP; Coimbra C; Gillard RM; Meunier P; Lechanteur C; Baudoux E; Boutaffala L; Beguin Y; Louis É
    J Crohns Colitis; 2023 May; 17(5):728-737. PubMed ID: 36733215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab.
    Bouguen G; Siproudhis L; Gizard E; Wallenhorst T; Billioud V; Bretagne JF; Bigard MA; Peyrin-Biroulet L
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):975-81.e1-4. PubMed ID: 23376316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience.
    Topstad DR; Panaccione R; Heine JA; Johnson DR; MacLean AR; Buie WD
    Dis Colon Rectum; 2003 May; 46(5):577-83. PubMed ID: 12792431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of local adalimumab injection in patients with fistulizing perianal Crohn's disease: a pilot study.
    Tonelli F; Giudici F; Asteria CR
    Dis Colon Rectum; 2012 Aug; 55(8):870-5. PubMed ID: 22810472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. INSPECT: A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel in Patients With Perianal Fistulizing Crohn's Disease Treated in the ADMIRE-CD Trial.
    Panés J; Bouma G; Ferrante M; Kucharzik T; Nachury M; de la Portilla de Juan F; Reinisch W; Selvaggi F; Tschmelitsch J; Brett NR; Ladouceur M; Binek M; Hantsbarger G; Campbell-Hill S; Karki C; Buskens C
    Inflamm Bowel Dis; 2022 Nov; 28(11):1737-1745. PubMed ID: 35099555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem Cell Therapy for the Treatment of Crohn's Disease; Current Obstacles and Future Hopes.
    El-Nakeep S
    Curr Stem Cell Res Ther; 2022; 17(8):727-733. PubMed ID: 34514993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Darvadstrocel for the treatment of perianal fistulas in Crohn's disease.
    Meng ZW; Baumgart DC
    Expert Rev Gastroenterol Hepatol; 2020 Jun; 14(6):405-410. PubMed ID: 32354239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role for dickkopf-homolog-1 in the pathogenesis of Crohn's disease-associated fistulae.
    Frei SM; Hemsley C; Pesch T; Lang S; Weber A; Jehle E; Rühl A; Fried M; Rogler G; Scharl M
    PLoS One; 2013; 8(11):e78882. PubMed ID: 24250816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perianal Fistula-Associated Carcinoma in Crohn's Disease: A Multicentre Retrospective Case Control Study.
    Palmieri C; Müller G; Kroesen AJ; Galata C; Rink AD; Morgenstern J; Kruis W
    J Crohns Colitis; 2021 Oct; 15(10):1686-1693. PubMed ID: 33772272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.